Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Total Current Liabilities of $17.0 million for Q4 2025, down 10.22% year-over-year from $18.9 million in Q4 2024, and down 9.75% quarter-over-quarter from $18.8 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Total Current Liabilities (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Total Current Liabilities for 3 consecutive years, with $17.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities fell 10.22% year-over-year to $17.0 million; the TTM figure through Dec 2025 stood at $17.0 million (down 10.22% YoY), while the FY2025 annual figure was $17.2 million, down 7.46% from the prior year.
- Total Current Liabilities eased to $17.0 million in Q4 2025 per ZYBT's latest filing, from $18.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $20.9 million in Q4 2023 and bottomed at $17.0 million in Q4 2025.
- Historically, Total Current Liabilities has averaged $18.9 million across 3 years, with a median of $18.9 million in 2024.
- Annual changes were most pronounced in 2024 — Total Current Liabilities slipped 9.32% — and 2025, when it dropped 10.22%.
- Zhengye Biotechnology Holding's Total Current Liabilities stood at $20.9 million in 2023, then retreated by 9.32% to $18.9 million in 2024, then decreased by 10.22% to $17.0 million in 2025.
- Business Quant data shows ZYBT's Total Current Liabilities at $17.0 million in Q4 2025, $18.8 million in Q2 2025, and $18.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Zhengye Biotechnology Holding | 85.40 Mn | 78.08 Mn | - | 16.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.99 Mn |
| Jun 30, 2025 | 18.82 Mn |
| Dec 31, 2024 | 18.92 Mn |
| Dec 31, 2023 | 20.87 Mn |